Conant v. Walters

Background: Proposition 215 and the federal backlash

In November 1996, California voters passed Proposition 215, the Compassionate Use Act, making California the first U.S. state to legalize medical cannabis ^[1]. The law allowed patients to possess and cultivate cannabis with a physician's 'recommendation' — language the drafters chose deliberately because a written 'prescription' for a Schedule I substance would violate federal law.

The Clinton administration responded within weeks. On December 30, 1996, drug czar Barry McCaffrey, Attorney General Janet Reno, and HHS Secretary Donna Shalala held a press conference announcing that any physician who recommended cannabis to a patient could lose their DEA registration to prescribe controlled substances, face exclusion from Medicare and Medicaid, and potentially be prosecuted ^[2][3]. The policy was formalized in a memorandum and became known as the 'McCaffrey policy.'

For doctors, losing a DEA number is effectively career-ending. The threat was meant to make Prop 215 unworkable by cutting off the supply of recommendations.

The plaintiffs and the lawsuit

In January 1997, a class of California physicians and patients sued in the Northern District of California. The lead plaintiff was Dr. Marcus Conant, a prominent San Francisco AIDS physician who had been recommending cannabis to wasting-syndrome patients since the 1980s ^[4]. Co-plaintiffs included doctors treating cancer and HIV patients and patients who relied on cannabis for symptom management.

The plaintiffs were represented by attorneys including Graham Boyd of the ACLU Drug Policy Litigation Project. Their argument was narrow and surgical: the case was not about whether cannabis worked, nor about whether patients had a right to use it. It was about whether the federal government could punish a doctor for the content of a conversation with a patient. That, they argued, was a First Amendment violation.

Judge Fern Smith issued a preliminary injunction in April 1997, and Judge William Alsup made it permanent in 2000, blocking the government from revoking DEA registrations based solely on recommendations ^[5].

The Ninth Circuit decision

The government appealed. By the time the case reached the Ninth Circuit, John Walters had replaced McCaffrey as drug czar, and the caption changed accordingly. On October 29, 2002, a three-judge panel — Judges Mary Schroeder, Betty Fletcher, and Alex Kozinski — unanimously affirmed the injunction ^[6].

The court held that a doctor's recommendation of cannabis is protected speech under the First Amendment. The government could still prosecute doctors who actually conspired with patients to obtain or distribute cannabis, but it could not punish the speech itself. The panel drew a clean line between recommending (protected) and aiding-and-abetting (not protected).

Judge Kozinski's concurrence is the most-cited part of the opinion. He wrote at length about the practical reality that millions of Americans were using cannabis medically, that the federal scheduling of cannabis as having 'no accepted medical use' was increasingly out of step with state law and clinical practice, and that doctors needed to be able to discuss it candidly with patients ^[6][7].

The Supreme Court declined to hear the government's appeal in October 2003 ^[8], leaving the Ninth Circuit ruling in place. While technically binding only in the Ninth Circuit, no other circuit has ruled differently, and the federal government has not attempted to revoke a DEA registration solely for a cannabis recommendation since.

Why it matters

Conant is the legal scaffolding that holds up the entire U.S. medical cannabis system. Every state medical program — from California's original Prop 215 framework to New York's certified-patient system — relies on a physician 'recommendation' or 'certification' rather than a prescription. That distinction only works because Conant established that the federal government cannot punish the recommendation itself ^[9].

It is worth being precise about what Conant did not do:

• It did not legalize medical cannabis under federal law. Cannabis remained Schedule I.
• It did not protect patients from federal arrest. That issue was litigated separately in Gonzales v. Raich (2005), which the patients lost.
• It did not protect dispensaries or growers. Those operations remained — and largely remain — federally illegal.
• It did not require doctors to recommend cannabis or insurers to cover it.

What it protected was a conversation. In the long arc of cannabis reform, that turned out to be enough to build an industry on.

Key figures

• Dr. Marcus Conant (1936–2021): San Francisco dermatologist and AIDS pioneer; lead plaintiff. Conant treated some of the first recognized AIDS patients in the U.S. and was an early advocate of medical cannabis for wasting syndrome ^[4].
• Barry McCaffrey: ONDCP Director under President Clinton; architect of the 1996 federal response.
• John Walters: ONDCP Director under President George W. Bush; named defendant on appeal.
• Graham Boyd: Lead ACLU attorney for plaintiffs.
• Judge Alex Kozinski: Authored the influential concurrence.

Sources

How this page was made